Navigation Links
JAMA study shows what works in treating HIV-infected African children
Date:10/24/2007

BIRMINGHAM, Ala. Providing HIV combination antiretroviral drug therapy is key to saving the lives of African children infected with the disease.

Letting nurses and other trained health care workers deliver that therapy and monitor patients, especially when doctors are in short supply, is just as important to saving lives, according to a new study by the University of Alabama at Birmingham (UAB).

Data for the study was gathered by following the health of 4,975 children for three years at the Centre for Infectious Disease Research in Zambia (CIDRZ), a nonprofit clinical, research and training center run by UAB faculty in conjunction with the Zambian government. The results are published in the Journal of the American Medical Association.

On average, children enrolled in the study experienced a more than doubling of their CD4 cell counts after one year of antiretrovirals, from an average of 12.9 percent CD4 count to 27 percent CD4 count, the researchers said.

The CD4 count is a blood test for a certain type of white blood cell that allows health care providers to monitor the effect of human immunodeficiency virus (HIV) on the immune system. Low CD4 counts are a sign of a weakening immune system, which puts patients at increased risk for developing AIDS and other opportunistic infections.

We know from work in the U.S. and Europe that children do well on antiretroviral drugs. But we were surprised in this study at just how high their CD4 counts went, and how quickly they went up, said Jeffrey Stringer, M.D., director of CIDRZ and a professor in UABs Department of Obstetrics and Gynecology.

In addition to the improvements seen in the CD4 counts, the UAB study found HIV-infected children who received antiretrovirals went up noticeably in what is called the weight-for-age score. This measurement is calculated from standardized pediatric growth charts and is used to monitor the health of HIV-infected infants
'/>"/>

Contact: Troy Goodman
tdgoodman@uab.edu
205-934-8938
University of Alabama at Birmingham
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Rural Canadians travel far for specialists: study
2. A new study surpasses Gene Therapy Hurdle
3. Tomato Sauce reduces Cancer Risk- Study
4. A question on study of Adult Stem Cell
5. Study on obesity and heart failure
6. National Lung Study in the process
7. Marijuana gateway theory strengthened by study of twins
8. Old theory of adaptation confirmed by new study
9. Study casts doubt on keyboard ills
10. Gene study links endometriosis, infertility
11. Study reveals how stress can make you sick
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:American Laser Centers Names Bill Van Huis as Chief Revenue Officer 2Health News:AT&T to Deliver Country's First Statewide eHealth Exchange Zone 2Health News:AT&T to Deliver Country's First Statewide eHealth Exchange Zone 3Health News:AT&T to Deliver Country's First Statewide eHealth Exchange Zone 4Health News:AT&T to Deliver Country's First Statewide eHealth Exchange Zone 5Health News:Acuo Technologies(R) Announces Record Sales and Implementation Growth 2Health News:Greenway Medical Technologies Strengthens Industry Leadership With Participation in the IHE Connectathon and HIMSS Interoperability Showcase 2Health News:Greenway Medical Technologies Strengthens Industry Leadership With Participation in the IHE Connectathon and HIMSS Interoperability Showcase 3Health News:Greenway Medical Technologies Strengthens Industry Leadership With Participation in the IHE Connectathon and HIMSS Interoperability Showcase 4Health News:Trial finds tenofovir gel safe for daily use and most women adhered to study regimens 2Health News:Trial finds tenofovir gel safe for daily use and most women adhered to study regimens 3Health News:Trial finds tenofovir gel safe for daily use and most women adhered to study regimens 4Health News:Trial finds tenofovir gel safe for daily use and most women adhered to study regimens 5Health News:Trial finds tenofovir gel safe for daily use and most women adhered to study regimens 6Health News:Harris Corporation Unveils Broadcast-Style Multiviewers for Real-Time Multi- Screen Access to Medical Information 2Health News:Harris Corporation Unveils Broadcast-Style Multiviewers for Real-Time Multi- Screen Access to Medical Information 3
Breaking Medicine Technology:Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals' Universal Flu Vaccine 2Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals' Universal Flu Vaccine 3Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals' Universal Flu Vaccine 4Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals' Universal Flu Vaccine 5Nplate(R) Data From MDS Studies Presented at ASH 2Nplate(R) Data From MDS Studies Presented at ASH 3Nplate(R) Data From MDS Studies Presented at ASH 4Nplate(R) Data From MDS Studies Presented at ASH 5Nplate(R) Data From MDS Studies Presented at ASH 6Nplate(R) Data From MDS Studies Presented at ASH 7Nplate(R) Data From MDS Studies Presented at ASH 8Nplate(R) Data From MDS Studies Presented at ASH 9Nplate(R) Data From MDS Studies Presented at ASH 10Multiple Sclerosis Patient Finds Hope Through Stem Cell Treatment 2New and Updated Online Tutorials for ArrayExpress Allen Brain Atlas and CleanEx from OpenHelix 54389 1New and Updated Online Tutorials for ArrayExpress Allen Brain Atlas and CleanEx from OpenHelix 54389 2New and Updated Online Tutorials for ArrayExpress Allen Brain Atlas and CleanEx from OpenHelix 54389 3Cancer Mortality Rates Experience Steady Decline 54386 1Cancer Mortality Rates Experience Steady Decline 54386 2Cancer Mortality Rates Experience Steady Decline 54386 3Cancer Mortality Rates Experience Steady Decline 54386 4APHL Chosen by PEPFAR to Develop Global Health Laboratory Systems 54384 1APHL Chosen by PEPFAR to Develop Global Health Laboratory Systems 54384 2